by Iqbal Pittalwala, University of California – Riverside Credit: CC0 Public DomainAfter COVID vaccination, it usually takes weeks for our bodies to develop protective antibody responses. Imagine, however, a vaccine that speeds up the production of antibodies against SARS-CoV-2, the virus that spreads COVID-19. A research team led by Rong Hai, an associate professor of microbiology...
by University of California, San Francisco Credit: Unsplash/CC0 Public Domain Despite some of the most successful international vaccination campaigns in history, the poliovirus continues to circulate around the world, posing a threat of neurological damage and even paralysis to anyone who is not vaccinated. While the original polio strains, called wildtype, have largely been eliminated, new strains can...
UNIVERSITY OF GEORGIA A new vaccine from the University of Georgia could be the first clinically approved immunization to protect against invasive fungal infections, a growing concern as antifungal drug resistance increases. Fungal infections cause more than 1.5 million deaths worldwide each year and cost billions. They also double hospitalization costs, double the length of hospital stays...
By Nicole Wetsman Aug 3, 2022, 4:26pm EDT Photo by PATRICK T. FALLON/AFP via Getty Images Here’s how a research study to test for antibodies might normally go: participants who sign up go to a medical office and get their blood drawn. Depending on the type of study, they might have to go back and forth multiple...
by Bob Yirka , Medical Xpress Credit: Pixabay/CC0 Public Domain A team of researchers affiliated with multiple institutions in the U.S. and one in Japan has developed a new type of vaccine that helps the immune system destroy cancerous tumors by overcoming their defense system. In their paper published in the journal Nature, the group describes...
by University of Oslo Credit: Unsplash/CC0 Public Domain A new vaccine against tuberculosis may also be used as treatment. The vaccine is safe to give to people with tuberculosis disease and strengthens the immune system’s ability to attack the bacteria that cause the disease, a new study shows. Tuberculosis is an infectious disease caused by the tubercle...
Interview conducted by Emily Henderson, B.Sc. Oct 25 2021 In this interview, News-Medical speaks to Professor Tomohiro Kurosaki about his research into the ongoing COVID-19 pandemic and how he has developed a new vaccine approach that could prevent future pandemics. Thought Leaders Professor Tomohiro Kurosaki Center for Infectious Diseases Education and Research Osaka University Please...
by Sarah Avery, Duke University School of Nursing Credit: Duke University School of Nursing A potential new vaccine developed by members of the Duke Human Vaccine Institute has proven effective in protecting monkeys and mice from a variety of coronavirus infections—including SARS-CoV-2 as well as the original SARS-CoV-1 and related bat coronaviruses that could potentially cause...
by Meghan Lepisto, University of Wisconsin-Madison This three-dimensional, semi-transparent rendering of a whole influenza virus shows both the clover-like surface proteins on the outside of the virus, as well as the internal ribonucleoproteins on the inside. Existing influenza vaccines introduce proteins found on the surface of flu viruses to help induce immune protection. A new study...
